Fig. 1
From: Prediction of myocardial ischemia–reperfusion injury post-PCI: role of sST2 levels in STEMI patients
Serum sST2 distribution (A) and ROC curve (B) for each subgroup of MIRI; ROC curve for predicting MIRI after PCI in STEMI patients using serum sST2, peak NT-proBNP, peak CK-MB, and peak cTnI (C);serum sST2 levels in patients with different outcomes (D); ROC curve for serum sST2 to predict all-cause mortality and MACCE in patients with MIRI (E); clinical outcomes and incidence of outcomes based on whether sST2 is greater than 68.98 ng/mL as the cutoff for clinical outcomes and the incidence of adverse events (F) (** P < 0.05 and ***P < 0.01)